• 1
    Ridker, P. M., Buring, J. E., Cook, N. R., Rifai, N. (2003) C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14,719 initially healthy American women. Circulation 107: 391397.
  • 2
    Pickup, J. C., Mattock, M. B., Chusney, G. D., Burt, D. (1997) NIDDM as a disease of the innate immune system: association of the acute-phase reactants and interleukin 6 with metabolic syndrome X. Diabetologia 40: 12861292.
  • 3
    Pickup, J. C., Crook, MA (1998) Is type II diabetes a disease of the innate immune system? Diabetologia 41: 12411248.
  • 4
    Fernández-Real, J. M., Ricart, W. (1999) Insulin resistance and inflammation in an evolutionary perspective. The contribution of cytokine genotype/phenotype to thriftiness. Diabetologia 42: 13671374.
  • 5
    Fernández-Real, J. M., Ricart, W. (2003) Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev. 24: 278301.
  • 6
    Dandona, P., Aljada, A., Chaudhuri, A., Mohanty, P., Garg, R. (2005) Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 111: 14481454.
  • 7
    Yudkin, J. S., Kumari, M., Humphries, S. E., Mohamed-Ali, V. (2000) Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 148: 209214.
  • 8
    Visser, M. R., Tracy, P. B., Vercellotti, G. M., Goodman, J. L., White, J. G., Jacob, HS (1999) Enhanced thrombin generation and platelet binding on herpes simplex virus-infected endothelium. Proc Natl Acad Sci U S A. 85: 82278230.
  • 9
    Key, N. S., Vercellotti, G. M., Winkelmann, J. C., et al (1990) Infection of vascular endothelial cells with herpes simplex virus enhances tissue factor activity and reduces thrombomodulin expression. Proc Natl Acad Sci U S A. 87: 70957099.
  • 10
    Kol, A., Sukhova, G. K., Lichtman, A. H., Libby, P. (1998) Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor- and matrix metalloproteinase expression. Circulation 98: 300307.
  • 11
    Dechend, R., Maass, M., Gieffers, J., et al (1999) Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-B and induces tissue factor and PAI-1 expression: a potential link to accelerated arteriosclerosis. Circulation 100: 13691373.
  • 12
    Lyons, M. J., Faust, I. M., Hemmes, R. B., Buskirk, D. R., Hirsch, J., Zabriskie, JB (1982) A virally induced obesity syndrome in mice. Science 216: 8285.
  • 13
    Bernard, A., Zwingelstein, G., Meister, R., Wild, Fabian T. (1988) Hyperinsulinemia induced by canine distemper virus infection of mice and its correlation with the appearance of obesity. Comp Biochem Physiol. 91B: 691696.
  • 14
    Carter, J. K., Garlich, J. D., Donaldson, W. T., Smith, RE (1983) Influence of diet on a retrovirus induced obesity and stunting syndrome. Avian Dis. 27: 317322.
  • 15
    Gosztonyi, G., Ludwig, H. (1995) Borna disease: neuropathology and pathogenesis. Curr Topics Microbiol Immunol. 190: 3973.
  • 16
    Atkinson, R. L., Dhurandhar, N. V., Allison, D. B., et al (2005) Human adenovirus-36 is associated with increased body weight and paradoxical reduction of serum lipids. Int J Obes Relat Metab Disord. 29: 281286.
  • 17
    Epstein, S. E., Zhou, Y. F., Zhu, J. (1999) Infection and atherosclerosis: emerging mechanistic paradigms. Circulation 100: e20e28.
  • 18
    Zhu, J., Nieto, F. J., Horne, B. D., Anderson, J. L., Muhlestein, J. B., Epstein, SE (2001) Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation 103: 4551.
  • 19
    Prasad, A., Zhu, J., Halcox, J. P. J., Waclawiw, M. A., Epstein, S. E., Quyyumi, AA (2002) Predisposition to atherosclerosis by infections. Role of endothelial dysfunction. Circulation 106: 184190.
  • 20
    Epstein, SE (2002) The multiple mechanisms by which infection may contribute to atherosclerosis development and course. Circ Res. 90: 24.
  • 21
    Espinola-Klein, C., Rupprecht, H. J., Blankenberg, S., et al. AtheroGene Investigators (2002) Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Circulation 105: 1521.
  • 22
    Smieja, M., Gnarpe, J., Lonn, E., et al. Heart Outcomes Prevention Evaluation (HOPE) Study Investigators (2003) Multiple infections, subsequent cardiovascular events, and atherosclerotic progression in the Heart Outcome and Prevention Evaluation (HOPE) Study. Circulation 107: 251257.
  • 23
    Pussinen, P. J., Nyyssonen, K., Alfthan, G., Salonen, R., Laukkanen, J. A., Salonen, JT (2005) Serum antibody levels to Actinobacillus actinomycetemcomitans predict the risk for coronary heart disease. Arterioscler Thromb Vasc Biol. 25: 833888.
  • 24
    Toplak, H., Wascher, T. C., Weber, K., et al (1995) Increased prevalence of serum IgA Chlamydia antibodies in obesity. Acta Med Austriaca 22: 2324.
  • 25
    Ekesbo, R., Nilsson, P. M., Lindholm, L. H., Persson, K., Wadstrom, T. (2003) Combined seropositivity for H. pylori and C. pneumoniae is associated with age, obesity and social factors. J Cardiovasc Risk 7: 191195.
  • 26
    Leinonen, M., Saikku, P. (1999) Interaction of Chlamydia pneumoniae infection with other risk factors of atherosclerosis. Am Heart J. 138: S504S506.
  • 27
    Laurila, A., Bloigu, A., Nayha, S., Hassi, J., Leinonen, M., Saikku, P. (1997) Chronic Chlamydia pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclerosis. Arterioscler Thromb Vasc Biol. 17: 29102913.
  • 28
    Murray, L. J., O'Reilly, D. P., Ong, G. M., O'Neill, C., Evans, A. E., Bamford, KB (1999) Chlamydia pneumoniae antibodies are associated with an atherogenic lipid profile. Heart 8: 239244.
  • 29
    Muller, J., Moller, D. S., Kjaer, M., Nyvad, O., Larsen, N. A., Pedersen, EB (2003) Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in healthy control subjects and patients with diabetes mellitus, acute coronary syndrome, stroke, and arterial hypertension. Scand J Infect Dis. 35: 704712.
  • 30
    Falck, G., Gnarpe, J., Hansson, L. O., Svardsudd, K., Gnarpe, H. (2002) Comparison of individuals with and without specific IgA antibodies to Chlamydia pneumoniae: respiratory morbidity and the metabolic syndrome. Chest 122: 15871593.
  • 31
    Kristensen, B. O., Andersen, P. L., Vestergaard, B. F., Andersen, HM (1982) Herpesvirus antibodies and vascular complications in essential hypertension. Acta Med Scand. 212: 375377.
  • 32
    Sun, Y., Pei, W., Wu, Y., Yang, Y. (2005) An association of herpes simplex virus type 1 infection with type 2 diabetes. Diabetes Care 28: 435436.
  • 33
    Sun, Y., Pei, W., Wu, Y., Jing, Z., Zhang, J., Wang, G. (2004) Herpes simplex virus type 2 infection is a risk factor for hypertension. Hypertens Res. 27: 541544.
  • 34
    Roberts, B. W., Cech, I. (2005) Association of type 2 diabetes mellitus and seroprevalence for cytomegalovirus. South Med J. 98: 686692.
  • 35
    Roivainen, M., Alfthan, G., Jousilahti, P., Kimpimaki, M., Hovi, T., Tuomilehto, J. (1998) Enterovirus infections as a possible risk factor for myocardial infarction. Circulation 98: 25342537.
  • 36
    Xu, F., Schillinger, J., Sternberg, M., et al (2002) Seroprevalence and coinfection with herpes simplex virus type 1 and type 2 in the United States, 1988–1994. J Infect Dis. 185: 10191024.
  • 37
    Cook, P. J., Honeybourne, D. (1995) Clinical aspects of Chlamydia pneumoniae infection. Presse Med. 24: 278282.
  • 38
    Finch, C. E., Crimmins, EM (2004) Inflammatory exposure and historical changes in human life-spans. Science 305: 17361739.
  • 39
    Tanaka, S. I., Inoue, S., Isoda, F., et al (1993) Impaired immunity in obesity: suppressed but reversible lymphocyte responsiveness. Int J Obes Relat Metab Disord. 17: 631636.
  • 40
    Greenway, F. (2006) Virus-induced obesity. Am J Physiol Regul Integr Comp Physiol. 290: R188R189.
  • 41
    Khanna, K. M., Lepisto, A. J., Decman, V., Hendricks, RL (2004) Immune control of herpes simplex virus during latency. Curr Opin Immunol. 16: 463469.
  • 42
    Ward, ME (1995) The immunobiology and immunopathology of chlamydial infections. APMIS 103: 769796.
  • 43
    Beatty, W. L., Morrison, R. P., Byrne, GI (1994) Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis. Microbiol Rev. 58: 686699.
  • 44
    Frisk, G. (2001) Mechanisms of chronic enteroviral persistence in tissue. Curr Opin Infect Dis. 14: 251256.
  • 45
    Harvala, H., Kalimo, H., Dahllund, L., et al (2002) Mapping of tissue tropism determinants in coxsackievirus genomes. J Gen Virol. 83: 16971706.